Shire plc: Director/PDMR Shareholding

Director/PDMR Shareholding

October 5, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the 'Company')

Notification of transactions by person discharging managerial responsibilities

+--+---------------------------------------------------------------------------+ |1.|Details of the person discharging managerial responsibilities ('PDMR') / | | |person closely associated them ('PCA') | +--+----------------------------------+----------------------------------------+ |a)|Name |Bill Mordan | +--+----------------------------------+----------------------------------------+ |2.|Reason for the notification | +--+----------------------------------+----------------------------------------+ |a)|Position / status |General Counsel and Company Secretary - | | | |PDMR | +--+----------------------------------+----------------------------------------+ |b)|Initial notification / amendment |Initial notification | +--+----------------------------------+----------------------------------------+ |3.|Details of the issuer, emission allowance participant, auction platform, | | |auctioneer or auction monitor | +--+----------------------------------+----------------------------------------+ |a)|Name |Shire plc | +--+----------------------------------+----------------------------------------+ |b)|LEI |54930005LQRLI2UXRQ59 | +--+----------------------------------+----------------------------------------+ |4.|Details of the transaction(s): section to be repeated for (i) each type of | | |instrument; (ii) each type of transaction; (iii) each date; and (iv) each | | |place where transactions have been conducted | +--+----------------------------------+----------------------------------------+ |a)|Description of the financial |Shire plc American Depositary Shares | | |instrument, type of instrument |('ADSs') | | | | | | | |  | | | | | | | |  | | | | | | |Identification code |ISIN: US82481R1068 | +--+----------------------------------+----------------------------------------+ |b)|Nature of the transaction |Receipt of ADSs following the vesting of| | | |Restricted Stock Units ('RSUs') awarded | | | |under the Shire Long Term Incentive Plan| | | |2015 ('LTIP') on February 12, 2016. The | | | |date of vesting follows the second | | | |anniversary of the originally intended | | | |date of grant of October 1, 2015. In | | | |accordance with the rules of the LTIP, | | | |upon vesting the number of ADSs to be | | | |delivered was increased by an amount | | | |equivalent to the value of dividends | | | |paid by the Company in respect of the | | | |RSUs from the award date to the date of | | | |vesting. | | | | | | | |  | | | | | | | |(Details of related disposal of ADSs are| | | |referenced in section 5. below.) | +--+----------------------------------+---------+------------------------------+ |c)|Price(s) and volume(s) |Price(s) | Volume(s) | | | +---------+------------------------------+ | | | $0 | 5,208 | +--+----------------------------------+---------+------------------------------+ |d)|Aggregated information |N/A (single transaction) | | | | | | |- Aggregated volume | | | | | | | |- Price | | +--+----------------------------------+----------------------------------------+ |e)|Date of the transaction |October 3, 2017 | +--+----------------------------------+----------------------------------------+ |f)|Place of the transaction |N/A | +--+----------------------------------+----------------------------------------+ |5.|Details of the transaction(s): section to be repeated for (i) each type of | | |instrument; (ii) each type of transaction; (iii) each date; and (iv) each | | |place where transactions have been conducted | +--+----------------------------------+----------------------------------------+ |a)|Description of the financial |Shire plc American Depositary Shares | | |instrument, type of instrument |('ADSs') | | | | | | | |  | | | | | | | |  | | | | | | |Identification code |ISIN: US82481R1068 | +--+----------------------------------+----------------------------------------+ |b)|Nature of the transaction |Automated disposal of ADSs in relation | | | |to the vesting of RSUs referenced in | | | |section 4. above. The proceeds of this | | | |disposal were used to satisfy personal | | | |tax liabilities arising from the vesting| | | |of the RSUs. | +--+----------------------------------+---------+------------------------------+ |c)|Price(s) and volume(s) |Price(s) | Volume(s) | | | +---------+------------------------------+ | | |$153.2803| 1,748 | +--+----------------------------------+---------+------------------------------+ |d)|Aggregated information |N/A (single transaction) | | | | | | |- Aggregated volume | | | | | | | |- Price | | +--+----------------------------------+----------------------------------------+ |e)|Date of the transaction |October 3, 2017 | +--+----------------------------------+----------------------------------------+ |f)|Place of the transaction |NASDAQ | +--+----------------------------------+----------------------------------------+

Oliver Strawbridge Senior Assistant Company Secretary For further information please contact:

Investor Relations

Ian Karp [e-mail] [phone]

Robert Coates [e-mail] [phone]

Media

Lisa Adler [e-mail] [phone]

Katie Joyce [e-mail] [phone]

NOTES TO EDITORS

About Shire

Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.

www.shire.com

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Shire plc via GlobeNewswire

B2QKY05R29

Copyright RTT News/dpa-AFX